The SmartPill Corporation
6
0
0
4
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
High Risk
Score: 75/100
16.7%
1 terminated/withdrawn out of 6 trials
80.0%
-6.5% vs industry average
0%
0 trials in Phase 3/4
25%
1 of 4 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (6)
Use of an Ambulatory Capsule to Characterize Gastrointestinal Pressure Patterns in Children
Role: collaborator
Transit Time and Bacterial Overgrowth Using SmartPill Capsule
Role: collaborator
Colonic Transit Time Validation Study
Role: lead
Assessment of Whole Gut Transit Time Using the SmartPill Capsule
Role: lead
A Comparison of SmartPill Capsule With Scintigraphy for Determining Gastric Residence Time - Over 65 Years Old
Role: lead
A Comparison of SmartPill Capsule With Scintigraphy for Determining Gastric Residence Time
Role: lead
All 6 trials loaded